（1）Decreased expression of AZGP1 is associated with poor prognosis in primary gastric cancer.（第一作者） （2）Decreased expression of transcription elongation factor A-like 7 is associated with gastric adenocarcinoma prognosis. （第一作者） （3）Relationship Between PD-L1 Expression and CD8+ T-cell Immune Responses in Hepatocellular Carcinoma.（第一作者） （4）Transforming Growth Factor β is a Poor Prognostic Factor and Inhibits the Favorable Prognostic Value of CD8+ CTL in Human Hepatocellular Carcinoma.（第一作者） （5）A childhood chemotherapy protocol improves overall survival among adults with T-lymphoblastic lymphoma. （共同第一作者） （6）Increased expression of stomatin-like protein 2 (STOML2) predicts decreased survival in gastric adenocarcinoma: a retrospective study. （共同通讯作者） （7）Decreased expression of the FOXO3a gene is associated with poor prognosis in primary gastric adenocarcinoma patients. （共同第一作者） （8）Reduced expression of ZDHHC2 is associated with lymph node metastasis and poor prognosis in gastric adenocarcinoma. （共同第一作者） （9）淋巴结阴性胃癌患者455例病理特征分析和辅助化疗的价值。（第一作者） （10）超声内镜在胃癌诊疗中的应用。（第一作者） （11）胃癌新辅助化疗1例（专著中的一章）。（第一作者） （12）A Network Meta-Analysis of Short and Long-Term Efficacy of Targeted Therapy With Single or Double-Drug Regimens in the Treatment of Stage III/IV Malignant Melanoma Based on 16 Randomized Controlled Trials.（第二作者） （13）IL-17 induces antitumor immunity by promoting beneficial neutrophil recruitment and activation in esophageal squamous cell carcinoma.（第三作者） （14）High level of COP1 expression is associated with poor prognosis in primary gastric cancer. （第五作者） （15）Reduced NKX2.1 expression predicts poor prognosis of gastric carcinoma. （第四作者） （16）Reduced expression of uroplakin 1A is associated with the poor prognosis of gastric adenocarcinoma patients. （第五作者）
